Council on Aging
The Medford Senior Center is located at 101 Riverside Ave.
Open 9 a.m. to 4 p.m. Monday through Friday.
Telephone: 781-396-6010
Announcements
Coffee & Conversation: 1-2 p.m. Thursdays. A way for older adults in the community to connect with others safely and easily by phone. No need to leave your home! Join Stephanie Chissler, coordinator of the Aging in Balance Department at MelroseWakefield Healthcare, for these weekly calls. Call in once or call in every week for conversation, support, resource sharing and tips to reduce stress and anxiety. Bring your own coffee or tea and join in the conversation. For information, call 1-646-558-8656. When asked, enter meeting ID #131-672-167##.
E-Mail
Boston - While overall emergency department visits have decreased during the pandemic, nonfatal opioid overdose visits have more than doubled. However, few patients who overdosed on opioids had received a prescription for naloxone, a medication designed to block the effects of opioids on the brain and rapidly reverse opioid overdose.
In a new study, clinician-researchers at Beth Israel Deaconess Medical Center (BIDMC) analyzed naloxone prescription trends during the COVID-19 pandemic in the United States and compared them to trends in opioid prescriptions and to overall prescriptions. The team s findings, published in the journal
JAMA Health Forum, suggest patents with opioid misuse disorders may be experiencing a dangerous decrease in access to the overdose-reversing drug.
Newswise Boston – Pregnant women with symptomatic COVID-19 have a higher risk of intensive care unit admissions, mechanical ventilation and death compared to non-pregnant reproductive age women. Increases in preterm birth and still birth have also been observed in pregnancies complicated by the viral infection. The Centers for Disease Control and Prevention (CDC) recommended that people who are pregnant may choose to be vaccinated at their own discretion with their healthcare provider. However, pregnant and lactating women were not included in Phase 3 vaccine efficacy trials; thus, data on vaccine safety and immunogenicity in this population is limited.
In a new study from Beth Israel Deaconess Medical Center (BIDMC), specialists in the Department of Obstetrics and Gynecology and the Center for Virology and Vaccine Research evaluated the immunogenicity of COVID-19 mRNA vaccines in pregnant and lactating women who received either the Pfizer or Moderna COVID-19 vaccines. The resea